Publication | Closed Access
Therapeutic Approach by a Novel Designed Anti-Inflammatory Drug, M2000, in Experimental Immune Complex Glomerulonephritis
42
Citations
14
References
2007
Year
These findings suggest that treatment with M2000 can reduce proteinuria, diminish antibody production, and suppress the progression of disease in a rat model of immune complex glomerulonephritis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1